Febrile neutropenia commonly complicates cancer chemotherapy. Outpatient treatment may reduce costs and improve patient comfort but risk progression of undetected medical problems
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Febrile neutropenia is a common complication of antineoplasic chemotherapy. It is a potentially seri...
Febrile neutropenia commonly complicates cancer chemotherapy. Outpatient treatment may reduce costs ...
BACKGROUND: Among patients who develop fever and neutropenia after having received cancer chemothera...
BACKGROUND: Febrile neutropenia is a serious complication of chemotherapy. The Multinational Associa...
PURPOSE: Reduced intensity therapy for children with low-risk febrile neutropenia may provide benefi...
Abstract Background Febrile neutropenia is a serious complication of chemotherapy. The Multinational...
Purpose: We recently demonstrated the efficacy of single-agent oral ofloxacin in the management of h...
Background: Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012....
Although consensus exists relating criteria for the identification of low-risk patients with febrile...
Purpose: We recently demonstrated the efficacy of single-agent oral ofloxacin in the management of h...
Febrile neutropenia is a common complication of antineoplasic chemotherapy. It is a potentially seri...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Febrile neutropenia is a common complication of antineoplasic chemotherapy. It is a potentially seri...
Febrile neutropenia commonly complicates cancer chemotherapy. Outpatient treatment may reduce costs ...
BACKGROUND: Among patients who develop fever and neutropenia after having received cancer chemothera...
BACKGROUND: Febrile neutropenia is a serious complication of chemotherapy. The Multinational Associa...
PURPOSE: Reduced intensity therapy for children with low-risk febrile neutropenia may provide benefi...
Abstract Background Febrile neutropenia is a serious complication of chemotherapy. The Multinational...
Purpose: We recently demonstrated the efficacy of single-agent oral ofloxacin in the management of h...
Background: Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012....
Although consensus exists relating criteria for the identification of low-risk patients with febrile...
Purpose: We recently demonstrated the efficacy of single-agent oral ofloxacin in the management of h...
Febrile neutropenia is a common complication of antineoplasic chemotherapy. It is a potentially seri...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Purpose To investigate the feasibility of withholding antibiotics and early discharge for patients w...
Febrile neutropenia is a common complication of antineoplasic chemotherapy. It is a potentially seri...
DOI
Add to ORKG